Wagstaff, J., Clarke, N., Ali, A., Ingleby, F., Hoyle, A., Amos, C., . . . James, N. (2019). Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: Long-term survival results from the STAMPEDE trial. Annals of Oncology, 30(12), pp. 1992-2003. doi:10.1093/annonc/mdz396
Chicago Style CitationWagstaff, John, et al. "Addition of Docetaxel to Hormonal Therapy in Low- and High-burden Metastatic Hormone Sensitive Prostate Cancer: Long-term Survival Results From the STAMPEDE Trial." Annals of Oncology 30, no. 12 (2019): 1992-2003.
MLA CitationWagstaff, John, et al. "Addition of Docetaxel to Hormonal Therapy in Low- and High-burden Metastatic Hormone Sensitive Prostate Cancer: Long-term Survival Results From the STAMPEDE Trial." Annals of Oncology 30.12 (2019): 1992-2003.